Table 3. Results summary.
| Base Case | Intervention: Improving non-MDR treatment quality | Intervention: Improving rapidity of MDR diagnosis | |
| Average 10-year Infectious MDR TB Prevalence starting after intervention completes in (cases out of 100,000): | |||
| 1997 | 22.4 | 16.0 | 22.5 |
| 2007 | 22.5 | 18.5 | 14.0 |
| 2017 | 25.4 | 22.7 | 15.4 |
| 2027 | 30.2 | 27.1 | 18.6 |
| Percentage reduction in infectious MDR TB prevalence (compared to analogous base-case time period): | |||
| 1997 | NA | 28.9% | NA (No DOTS-Plus) |
| 2007 | NA | 17.6% | 38.0% |
| 2017 | NA | 10.8% | 39.2% |
| 2027 | NA | 10.3% | 38.5% |
Percentage reduction in infectious MDR TB prevalence also shown graphically in Figure 5.